Nivolumab versus investigator’s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age
Titel:
Nivolumab versus investigator’s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age
Auteur:
Saba, Nabil F. Blumenschein Jr., George Guigay, Joel Licitra, Lisa Fayette, Jerome Harrington, Kevin J. Kiyota, Naomi Gillison, Maura L. Ferris, Robert L. Jayaprakash, Vijayvel Li, Li Brossart, Peter